Neutrophilic dermatoses as systemic diseases

Clinics in Dermatology

Volumn 32, Issue 3, 2014, Pages 376-388

  Prat, Lola ^a,b   Bouaziz, Jean David ^a,b   Wallach, Daniel ^a,b   Vignon Pennamen, Marie Dominique ^a,b   Bagot, Martine ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE GRANULOCYTIC LEUKEMIA; ANKYLOSING SPONDYLITIS; AUTOINFLAMMATORY DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; ERYTHEMA; ERYTHEMA ELEVATUM DIUTINUM; HUMAN; IDIOPATHIC DISEASE; IGA PEMPHIGUS; INFLAMMATORY BOWEL DISEASE; LEUKEMIA; LYMPHOMA; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NEUTROPHILIC DERMATOSES; NOTE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RHEUMATOID ARTHRITIS; SKIN DISEASE; SUBCORNEAL PUSTULAR DERMATOSIS; SYSTEMIC DISEASE; BULLOUS SKIN DISEASE; COMPLICATION; HEMATOLOGIC DISEASE; LEUKOCYTOCLASTIC VASCULITIS; LUNG DISEASE; MUSCULOSKELETAL DISEASE; NEUTROPHIL; PATHOLOGY;

HEMATOLOGIC DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; LUNG DISEASES; MUSCULOSKELETAL DISEASES; NEUTROPHILS; PYODERMA GANGRENOSUM; SKIN DISEASES, VESICULOBULLOUS; SWEET SYNDROME; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 84899087519     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2013.11.004     Document Type: Note

References (145)

1. Wallach D., Vignon-Pennamen M.-D. From acute febrile neutrophilic dermatosis to neutrophilic disease: Forty years of clinical research. J Am Acad Dermatol 2006, 55:1066-1071.
2. Johnson M.L., Grimwood R.E. Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 1994, 130:77-81.
3. Huang W., McNeely M.C. Neutrophilic tissue reactions. Adv Dermatol 1997, 13:33-64.
4. Vignon-Pennamen M.D., Wallach D. Neutrophilic disease: A review of extra-cutaneous neutrophilic manifestations. Eur J Dermatol 1995, 5:449-455.
5. André M.F.J., Piette J.-C., Kémény J.-L., et al. Aseptic abscesses: A study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine (Baltimore) 2007, 86:145-161.
6. Sweet R.D. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964, 76:349-356.
7. Chan M.P., Duncan L.M., Nazarian R.M. Subcutaneous Sweet syndrome in the setting of myeloid disorders: A case series and review of the literature. J Am Acad Dermatol 2013, 68:1006-1015.
8. Cohen P.R. Sweet's syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007, 2:34.
9. Cohen P.R. Skin lesions of Sweet syndrome and its dorsal hand variant contain vasculitis: An oxymoron or an epiphenomenon?. Arch Dermatol 2002, 138:400-403.
10. Hensley C.D., Caughman S.W. Neutrophilic dermatoses associated with hematologic disorders. Clin Dermatol 2000, 18:355-367.
11. Cohen P.R., Talpaz M., Kurzrock R. Malignancy-associated Sweet's syndrome: Review of the world literature. J Clin Oncol 1988, 6:1887-1897.
12. Feliu E., Cervantes F., Ferrando J., et al. Neutrophilic pustulosis associated with chronic myeloid leukemia: A special form of Sweet's syndrome. Report of two cases. Acta Haematol 1992, 88:154-157.
13. Clemmensen O.J., Menné T., Brandrup F., et al. Acute febrile neutrophilic dermatosis-a marker of malignancy?. Acta Derm Venereol 1989, 69:52-58.
14. Bourke S.J., Quinn A.G., Farr P.M., et al. Neutrophilic alveolitis in Sweet's syndrome. Thorax 1992, 47:572-573.
15. Bamelis M., Boyden B., Sente F., et al. Sweet's syndrome and acute myelogenous leukemia in a patient who presented with a sudden massive swelling of the tongue. Dermatology (Basel) 1995, 190:335-337.
16. Cooper P.H., Innes D.J., Greer K.E. Acute febrile neutrophilic dermatosis (Sweet's syndrome) and myeloproliferative disorders. Cancer 1983, 51:1518-1526.
17. Hansen U., Haerslev T., Knudsen B., et al. Erythema elevatum diutinum: Case report showing an unusual distribution. Cutis 1994, 53:124-126.
18. Yiannias J.A., el-Azhary R.A., Gibson L.E. Erythema elevatum diutinum: A clinical and histopathologic study of 13 patients. J Am Acad Dermatol 1992, 26:38-44.
19. Sangüeza O.P., Pilcher B., Martin Sangüeza J. Erythema elevatum diutinum: A clinicopathological study of eight cases. Am J Dermatopathol 1997, 19:214-222.
20. Franks A.G. Skin manifestations of internal disease. Med Clin North Am 2009, 93:1265-1282.
21. Flynn T.C., Harrist T.J., Murphy G.F., et al. Neutrophilic eccrine hidradenitis: A distinctive rash associated with cytarabine therapy and acute leukemia. J Am Acad Dermatol 1984, 11(4 Pt 1):584-590.
22. Scherbenske J.M., Benson P.M., Lupton G.P., et al. Rheumatoid neutrophilic dermatitis. Arch Dermatol 1989, 125:1105-1108.
23. Wilson-Jones E., Winkelmann R.K. Superficial granulomatous pyoderma: A localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 1988, 18:511-521.
24. Brunsting L.A., Goeckerman W.H., O'Leary P.A. Pyoderma (ecthyma) gangrenosum: Clinical and experimental observation in five cases occurring in adults. Arch Dermatol Syph 1930, 22:655.
25. Ahronowitz I., Harp J., Shinkai K. Etiology and management of pyoderma gangrenosum: A comprehensive review. Am J Clin Dermatol 2012, 13:191-211.
26. Ko C.B., Walton S., Wyatt E.H. Pyoderma gangrenosum: Associations revisited. Int J Dermatol 1992, 31:574-577.
27. Von den Driesch P. Pyoderma gangrenosum: A report of 44 cases with follow-up. Br J Dermatol 1997, 137:1000-1005.
28. Bennett M.L., Jackson J.M., Jorizzo J.L., et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000, 79:37-46.
29. Farhi D., Cosnes J., Zizi N., et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: A cohort study of 2402 patients. Medicine (Baltimore) 2008, 87:281-293.
30. Charles C.A., Leon A., Banta M.R., et al. Etanercept for the treatment of refractory pyoderma gangrenosum: A brief series. Int J Dermatol 2007, 46:1095-1099.
31. Powell F.C., Su W.P., Perry H.O. Pyoderma gangrenosum: Classification and management. J Am Acad Dermatol 1996, 34:395-409. [quiz 410-412].
32. Montoto S., Bosch F., Estrach T., Blade J., et al. Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukemia. Leuk Lymphoma 1998, 30:199-202.
33. Lewerin C., Mobacken H., Nilsson-Ehle H., et al. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy. Leuk Lymphoma 1997, 26:629-632.
34. Duguid C.M., O'Loughlin S., Otridge B., et al. Paraneoplastic pyoderma gangrenosum. Australas J Dermatol 1993, 34:17-22.
35. Caughman W., Stern R., Haynes H. Neutrophilic dermatosis of myeloproliferative disorders. Atypical forms of pyoderma gangrenosum and Sweet's syndrome associated with myeloproliferative disorders. J Am Acad Dermatol 1983, 9:751-758.
36. Akatsuka T., Kawata T., Hashimoto S., et al. Rapidly progressive renal failure occurring in the course of pyoderma gangrenosum and IgA (lambda) monoclonal gammopathy. Intern Med 1997, 36:40-43.
37. Brown T.S., Marshall G.S., Callen J.P. Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: A rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol 2000, 43(1 Pt 1):108-112.
38. Kitagawa K.H., Grassi M. Primary pyoderma gangrenosum of the lungs. J Am Acad Dermatol 2008, 59(5 Suppl):S114-S116.
39. Sutra-Loubet C., Carlotti A., Guillemette J., et al. Neutrophilic panniculitis. J Am Acad Dermatol 2004, 50:280-285.
40. Kato S., Hosomi E., Amano F., et al. The efficacy of intensive granulocyte and monocyte adsorption apheresis in a patient with Crohn's disease complicated by extensive subcutaneous aseptic neutrophilic abscesses. J Crohns Colitis 2012, 6:787-791.
41. Magro C.M., Crowson A.N. The spectrum of cutaneous lesions in rheumatoid arthritis: A clinical and pathologic study of 43 patients. J Cutan Pathol 2003, 30:1-10.
42. Tran T.A., DuPree M., Carlson J.A. Neutrophilic lobular (pustular) panniculitis associated with rheumatoid arthritis: A case report and review of the literature. Am J Dermatopathol 1999, 21:247-252.
43. Yosipovitch G., Hodak E., Feinmesser M., et al. Acute Crohn's colitis with lobular panniculitis-metastatic Crohn's?. J Eur Acad Dermatol Venereol 2000, 14:405-406.
44. Becherer K., Golda N., Feldman M., et al. Neutrophilic panniculitis associated with myelodysplastic syndrome with abnormal nuclear forms. J Cutan Pathol 2009, 36:1024-1026.
45. Kim I.-H., Youn J.-H., Shin S.-H., et al. Neutrophilic panniculitis following azacitidine treatment for myelodysplastic syndromes. Leuk Res 2012, 36:e146-e148.
46. De Masson A., Bouvresse S., Clérici T., et al. Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib. Ann Dermatol Venereol 2011, 138:135-139.
47. Monfort J.-B., Pagès C., Schneider P., et al. Vemurafenib-induced neutrophilic panniculitis. Melanoma Res 2012, 22:399-401.
48. Kim G.H., Levy A., Compoginis G. Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib. J Cutan Pathol 2013, 40:667-669.
49. Sneddon I.B., Wilkinson D.S. Subcorneal pustular dermatosis. Br J Dermatol 1956, 68:385-394.
50. Lutz M.E., Daoud M.S., McEvoy M.T., et al. Subcorneal pustular dermatosis: A clinical study of ten patients. Cutis 1998, 61:203-208.
51. Reed J., Wilkinson J. Subcorneal pustular dermatosis. Clin Dermatol 2000, 18:301-313.
52. Bordignon M., Zattra E., Montesco M.C., et al. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: Case report and literature review. Am J Clin Dermatol 2008, 9:51-55.
53. Cheng S., Edmonds E., Ben-Gashir M., et al. Subcorneal pustular dermatosis: 50 years on. Clin Exp Dermatol 2008, 33:229-233.
54. Chimenti S., Ackerman A.B. Is subcorneal pustular dermatosis of Sneddon and Wilkinson an entity sui generis?. Am J Dermatopathol 1981, 3:363-376.
55. Murphy G.M., Griffiths W.A. Subcorneal pustular dermatosis. Clin Exp Dermatol 1989, 14:165-167.
56. Park B.S., Cho K.H., Eun H.C., et al. Subcorneal pustular dermatosis in a patient with aplastic anemia. J Am Acad Dermatol 1998, 39(2 Pt 1):287-289.
57. Wallach D., Foldès C., Cottenot F. Subcorneal pustulosis, superficial acantholysis and monoclonal IgA. Ann Dermatol Venereol 1982, 109:959-963.
58. Huff J.C., Golitz L.E., Kunke K.S. Intraepidermal neutrophilic IgA dermatosis. N Engl J Med 1985, 313:1643-1645.
59. Wallach D. Intraepidermal IgA pustulosis. J Am Acad Dermatol 1992, 27(6 Pt 1):993-1000.
60. Tsuruta D., Ishii N., Hamada T., et al. IgA pemphigus. Clin Dermatol 2011, 29:437-442.
61. Jorizzo J.L., Apisarnthanarax P., Subrt P., et al. Bowel-bypass syndrome without bowel bypass. Bowel-associated dermatosis-arthritis syndrome. Arch Intern Med 1983, 143:457-461.
62. Marzano A.V., Ramoni S., Caputo R. Amicrobial pustulosis of the folds. Report of 6 cases and a literature review. Dermatology (Basel) 2008, 216:305-311.
63. Andre M., Aumaitre O., Marcheix J.C., et al. Aseptic systemic abscesses preceding diagnosis of Crohn's disease by 3 years. Dig Dis Sci 1995, 40:525-527.
64. Astudillo L., Sailler L., Launay F., et al. Pulmonary involvement in Sweet's syndrome: A case report and review of the literature. Int J Dermatol 2006, 45:677-680.
65. Longo M.I., Pico M., Bueno C., et al. Sweet's syndrome and bronchiolitis obliterans organizing pneumonia. Am J Med 2001, 111:80-81.
66. Christ E., Linka A., Jacky E., et al. Sweet's syndrome involving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid. Leukemia 1996, 10:731-734.
67. Batalla A., Pérez-Pedrosa A., García-Doval I., et al. Lung involvement in pyoderma gangrenosum: A case report and review of the literature. Actas Dermosifiliogr 2011, 102:373-377.
68. Merke D.P., Honig P.J., Potsic W.P. Pyoderma gangrenosum of the skin and trachea in a 9-month-old boy. J Am Acad Dermatol 1996, 34:681-682.
69. Thurnheer R., Stammberger U., Hailemariam S., et al. Bronchial manifestation of acute febrile neutrophilic dermatosis (Sweet's syndrome). Eur Respir J 1998, 11:978-980.
70. Giedion A., Holthusen W., Masel L.F., et al. Subacute and chronic "symmetric" osteomyelitis. Ann Radiol (Paris) 1972, 15:329-342.
71. Gamble J.G., Rinsky L.A. Chronic recurrent multifocal osteomyelitis: A distinct clinical entity. J Pediatr Orthop 1986, 6:579-584.
72. Van Howe R.S., Starshak R.J., Chusid M.J. Chronic, recurrent multifocal osteomyelitis. Case report and review of the literature. Clin Pediatr (Phila) 1989, 28:54-59.
73. Tlougan B.E., Podjasek J.O., O'Haver J., et al. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: A report of seven cases and review of the literature. Pediatr Dermatol 2009, 26:497-505.
74. Vignon-Pennamen M.D. The extracutaneous involvement in the neutrophilic dermatoses. Clin Dermatol 2000, 18:339-347.
75. Holt P.J., Davies M.G., Saunders K.C., et al. Pyoderma gangrenosum: Clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) 1980, 59:114-133.
76. Wright V., Watkinson G. The arthritis of ulcerative colitis. Medicine (Baltimore) 1959, 38:243-262.
77. Hisanaga K., Hosokawa M., Sato N., et al. "Neuro-sweet disease": benign recurrent encephalitis with neutrophilic dermatosis. Arch Neurol 1999, 56:1010-1013.
78. Hisanaga K., Iwasaki Y., Itoyama Y. Neuro-Sweet disease: Clinical manifestations and criteria for diagnosis. Neurology 2005, 64:1756-1761.
79. Chanson P., Timsit J., Kujas M., et al. Pituitary granuloma and pyoderma gangrenosum. J Endocrinol Invest 1990, 13:677-681.
80. Fett D.L., Gibson L.E., Su W.P. Sweet's syndrome: Systemic signs and symptoms and associated disorders. Mayo Clin Proc 1995, 70:234-240.
81. Actis G.C., Ottobrelli A., Lavezzo B., et al. Recurrent necroinflammatory disease of multiple organs and colon. Systemic presentation of inflammatory bowel disease or gut involvement during systemic disorder. Dig Dis Sci 1996, 41:2100-2105.
82. Hastier P., Caroli-Bosc F.X., Bartel H.R., et al. Pyoderma gangrenosum with hepatopancreatic manifestations in a patient with rheumatoid arthritis. Dig Dis Sci 1996, 41:594-597.
83. Costa I., Castanet J., Taillan B. et al. Ann Dermatol Venereol 1994, 121:550-552.
84. Moreland L.W., Brick J.E., Kovach R.E., et al. Acute febrile neutrophilic dermatosis (Sweet syndrome): A review of the literature with emphasis on musculoskeletal manifestations. Semin Arthritis Rheum 1988, 17:143-153.
85. Marie I., Levesque H., Joly P., et al. Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis. J Am Acad Dermatol 2001, 44:137-139.
86. Attias D., Laor R., Zuckermann E., et al. Acute neutrophilic myositis in Sweet's syndrome: Late phase transformation into fibrosing myositis and panniculitis. Hum Pathol 1995, 26:687-690.
87. Muster A.J., Bharati S., Herman J.J., et al. Fatal cardiovascular disease and cutis laxa following acute febrile neutrophilic dermatosis. J Pediatr 1983, 102:243-248.
88. Shimizu K. Neutrophilic infiltration of the myocardium in a patient with myelodysplastic syndrome. Am J Hematol 1998, 58:337-338.
89. Koester G., Tarnower A., Levisohn D., et al. Bullous pyoderma gangrenosum. J Am Acad Dermatol 1993, 29(5 Pt 2):875-878.
90. Gottlieb C.C., Mishra A., Belliveau D., et al. Ocular involvement in acute febrile neutrophilic dermatosis (Sweet syndrome): New cases and review of the literature. Surv Ophthalmol 2008, 53:219-226.
91. Wilson D.M., John G.R., Callen J.P. Peripheral ulcerative keratitis-an extracutaneous neutrophilic disorder: Report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet's syndrome with an excellent response to cyclosporine therapy. J Am Acad Dermatol 1999, 40(2 Pt 2):331-334.
92. Gunawardena D.A., Gunawardena K.A., Ratnayaka R.M., et al. The clinical spectrum of Sweet's syndrome (acute febrile neutrophilic dermatosis)-a report of eighteen cases. Br J Dermatol 1975, 92:363-373.
93. Marzano A.V., Ishak R.S., Lazzari R., et al. Vulvar pyoderma gangrenosum with renal involvement. Eur J Dermatol 2012, 22:537-539.
94. Sitjas D., Puig L., Cuatrecasas M., et al. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Int J Dermatol 1993, 32:261-268.
95. Matta M., Malak J., Tabet E., et al. Sweet's syndrome: Systemic associations. Cutis 1973, 12:561-566.
96. Von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994, 31:535-556. [quiz 557-560].
97. Unis M.E., Hill G.S. Sweet's syndrome associated with acute renal failure. Cutis 1987, 40:139-142.
98. Su L.-H., Chiu H.-C., Hsiao C.-H. Multiple neutrophilic dermatoses occurring in a pediatric patient with glomerulonephritis. J Am Acad Dermatol 2005, 52(2 Suppl 1):28-30.
99. Cartier H., Plantin P., Leroy J.P., et al. Pyoderma gangrenosum, subcorneal IgA pustulosis and recurrent neutrophilic pleural and pulmonary diseases in a patient with IgA gammopathy. Ann Dermatol Venereol 1995, 122:97-101.
100. Dinulescu M., Vigy P., Droitcourt C., et al. Pyoderma gangrenosum and aseptic pyosalpinx in a pregnant patient. Ann Dermatol Venereol 2007, 134:179-180.
101. Sujobert P., Cuccuini W., Vignon-Pennamen D., et al. Evidence of differentiation in myeloid malignancies associated neutrophilic dermatosis: A fluorescent in situ hybridization study of 14 patients. J Invest Dermatol 2013, 133:1111-1114.
102. Uhara H., Saida T., Nakazawa H., et al. Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor. J Am Acad Dermatol 2008, 59(2 Suppl 1):S10-S12.
103. Walling H.W., Snipes C.J., Gerami P., et al. The relationship between neutrophilic dermatosis of the dorsal hands and sweet syndrome: Report of 9 cases and comparison to atypical pyoderma gangrenosum. Arch Dermatol 2006, 142:57-63.
104. Levi I., Raanani P., Shalmon B., et al. Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia. Leuk Lymphoma 1999, 34:401-404.
105. Roustan G., Salas C., Cabrera R., et al. Neutrophilic eccrine hidradenitis unassociated with chemotherapy in a patient with acute myelogenous leukemia. Int J Dermatol 2001, 40:144-147.
106. Bakhshi S., Sethuraman G., Singh M.K., et al. Atypical pyoderma gangrenosum as a manifestation of childhood acute lymphoblastic leukemia. Pediatr Dermatol 2005, 22:543-545.
107. Kanzaki H., Oono T., Makino E., et al. Neutrophilic eccrine hidradenitis: Report of two cases. J Dermatol 1995, 22:137-142.
108. Woodrow S.L., Munn S.E., Basarab T., et al. Sweet's syndrome in association with non-Hodgkin's lymphoma. Clin Exp Dermatol 1996, 21:357-359.
109. Hünermund A., Wendel A.-M., Geissinger E., et al. Typically atypical: Histiocytoid Sweet syndrome, associated with malignancy. J Dtsch Dermatol Ges 2011, 9:666-669.
110. Thuillier D., Lenglet A., Chaby G., Royer R., Vaida I., Viseux V., et al. Bortezomib-induced eruption: Sweet syndrome? Two case reports. Ann Dermatol Venereol 2009, 136:427-430.
111. Decaux O., Laurat E., Perlat A., Cazalets C., Jego P., Grosbois B. Systemic manifestations of monoclonal gammopathy. Eur J Intern Med 2009, 20:457-461.
112. Bayer-Garner I.B., Smoller B.R. The spectrum of cutaneous disease in multiple myeloma. J Am Acad Dermatol 2003, 48:497-507.
113. Harada Y., Egi Y., Honda Y., Shirota T., et al. Multiple myeloma with Sweet disease developing from monoclonal gammopathy of undetermined significance and Sjögren syndrome. Rinsho Ketsueki 2001, 42:1176-1180.
114. Tanguy-Schmidt A., Avenel-Audran M., Croué A., et al. Bortezomib-induced acute neutrophilic dermatosis. Ann Dermatol Venereol 2009, 136:443-446.
115. Van Regenmortel N., Van de Voorde K., De Raeve H., et al. Bortezomib-induced Sweet's syndrome. Haematologica 2005, 90(12 Suppl):ECR43.
116. Reina D., Cerdà D., Roig D., et al. Sweet syndrome associated with myelodysplastic syndrome: Report of a case. Review of the literature. Rheumatol Clin 2013, 9:246-247.
117. Trickett H.B., Cumpston A., Craig M. Azacitidine-associated Sweet's syndrome. Am J Health Syst Pharm 2012, 69:869-871.
118. Van Loon K., Gill R.M., McMahon P., et al. 20q- clonality in a case of oral sweet syndrome and myelodysplasia. Am J Clin Pathol 2012, 137:310-315.
119. Larsen S., Bendtzen K., Nielsen O.H. Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management. Ann Med 2010, 42:97-114.
120. Rothfuss K.S., Stange E.F., Herrlinger K.R. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 2006, 12:4819-4831.
121. Trost L.B., McDonnell J.K. Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J 2005, 81:580-585.
122. Bernstein C.N., Blanchard J.F., Rawsthorne P. The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study. Am J Gastroenterol 2001, 96:1116-1122.
123. Fahmy M., Ramamoorthy S., Hata T., Sandborn W.J. Ustekinumab for peristomal pyoderma gangrenosum. Am J Gastroenterol 2012, 107:794-795.
124. Sommer S., Wilkinson S.M., Merchant W.J., et al. Sweet's syndrome presenting as palmoplantar pustulosis. J Am Acad Dermatol 2000, 42(2 Pt 2):332-334.
125. André M.F.J., Aumaître O., Grateau G., et al. Longest form of CCTG microsatellite repeat in the promoter of the CD2BP1/PSTPIP1 gene is associated with aseptic abscesses and with Crohn disease in French patients. Dig Dis Sci 2010, 55:1681-1688.
126. Yamamoto T. Cutaneous manifestations associated with rheumatoid arthritis. Rheumatol Int 2009, 29:979-988.
127. Sayah A., English J.C. Rheumatoid arthritis: A review of the cutaneous manifestations. J Am Acad Dermatol 2005, 53:191-209. [quiz 210-212].
128. Powell F.C., Schroeter A.L., Su W.P., et al. Pyoderma gangrenosum: A review of 86 patients. Q J Med 1985, 55:173-186.
129. Hickman J.G., Lazarus G.S. Pyoderma gangrenosum: A reappraisal of associated systemic diseases. Br J Dermatol 1980, 102:235-237.
130. Nakamura T., Higashi S., Tomoda K., et al. Cutaneous nodules in patients with rheumatoid arthritis: A case report and review of literatures. Clin Rheumatol 2011, 30:719-722.
131. Fujio Y., Funakoshi T., Nakayama K., et al. Rheumatoid neutrophilic dermatosis with tense blister formation: A case report and review of the literature. Australas J Dermatol 2012, [Epub ahead of print].
132. Stephenson S.R., Campbell S.M., Drew G.S., et al. Palisaded neutrophilic and granulomatous dermatitis presenting in a patient with rheumatoid arthritis on adalimumab. J Cutan Pathol 2011, 38:644-648.
133. Mansouri S., Abourazzak F.E., Aradoini N., et al. Ankylosing spondylitis associated with Sweet's syndrome: A case report. J Med Case Rep 2013, 7:16.
134. Petermann A., Tebbe B., Distler A., et al. Sweet's syndrome in a patient with acute Crohn's colitis and longstanding ankylosing spondylitis. Clin Exp Rheumatol 1999, 17:607-610.
135. Belfiore N., Caporali R., Borroni G., et al. Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease. Clin Exp Rheumatol 1997, 15:667-669.
136. Wise C.A., Gillum J.D., Seidman C.E., et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 2002, 11:961-969.
137. Braun-Falco M., Kovnerystyy O., Lohse P., Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 2012, 66:409-415.
138. Ferguson P.J., Chen S., Tayeh M.K., et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 2005, 42:551-557.
139. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
140. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
141. Lipsker D., Perrigouard C., Foubert A., et al. Anakinra for difficult-to-treat neutrophilic panniculitis: IL-1 blockade as a promising treatment option for neutrophil-mediated inflammatory skin disease. Dermatology (Basel) 2010, 220:264-267.
142. Kluger N., Gil-Bistes D., Guillot B., et al. Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret®) in a case of refractory Sweet's syndrome. Dermatology (Basel) 2011, 222:123-127.
143. Marzano A.V., Cugno M., Trevisan V., et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 2010, 162:100-107.
144. Guenova E., Teske A., Fehrenbacher B., et al. Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. Arch Dermatol 2011, 147:1203-1205.
145. Hitzler J.K., Martinez-Valdez H., Bergsagel D.B., et al. Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease. Blood 1991, 78:1996-2004.